Delhi HC Bars Zydus from Selling Generic Upadacitinib but Allows Manufacturing to Continue

In an AbbVie patent suit over Rinvoq rival Ikra, Delhi High Court grants partial interim relief—halting commercialization while preserving Zydus's production capacity and jobs pending full trial.

ndtv-profit-business · 7/13/2026, 12:17:59 PM · Ask about this →